Diffusion tensor MRI better than T2-weighted for evaluating diseased brain tissue in MS patients

August 02, 2004

Areas of abnormal white matter in the brains of multiple sclerosis (MS) patients appear much larger on diffusion tensor MRI than on T2-weighted MRI, a finding which could impact therapy options, according to a new study by researchers from Duke University Medical Center in Durham, NC.

The study analyzed 36 white matter plaques in 20 patients with MS who underwent both T2-weighted and diffusion tensor MRI. By measuring the degree to which water molecules spread in a particular direction--called fractional anisotropy (FA)--which is altered with damage to the nerve axons, the researchers discovered that the average area of focally abnormal white matter on diffusion tensor imaging was 87 mm2, 45% more than the average plaque area seen on T2-weighted images.

The researchers believe that besides measuring the degree of diseased white matter more accurately than T2-weighted imaging, diffusion tensor imaging may also show abnormalities earlier than T2-weighted imaging. "T2-weighted imaging does give us excellent anatomic detail of the brain and the distribution of destructive plaques in MS. However, relatively significant alteration in the tissue is necessary before we can see signal changes on T2-weighted images. Using diffusion tensor imaging, we are able to produce maps of water diffusion in the brain that help us identify damaged areas before the changes are severe enough to be detected on T2-weighted images," said Susan M. Kealey, MD, lead author of the paper.

According to Dr. Kealey, this finding could impact future treatment of MS. "Currently, many major trials of the effectiveness of various therapies for MS use the volume of affected white matter as seen on T2-weighted images as a marker of the response to therapy. Diffusion tensor imaging may be a more sensitive way of measuring the true lesion load in MS and therefore may be more sensitive in assessing the effectiveness of various therapies," she said.
-end-
The article appears in the August 2004 issue of the American Journal of Roentgenology.

American College of Radiology

Related Multiple Sclerosis Articles from Brightsurf:

New therapy improves treatment for multiple sclerosis
A new therapy that binds a cytokine to a blood protein shows potential in treating multiple sclerosis, and may even prevent it.

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.

New therapeutic options for multiple sclerosis in sight
Strategies for treating multiple sclerosis have so far focused primarily on T and B cells.

Diet has an impact on the multiple sclerosis disease course
The short-chain fatty acid propionic acid influences the intestine-mediated immune regulation in people with multiple sclerosis (MS).

The gut may be involved in the development of multiple sclerosis
It is incompletely understood which factors in patients with multiple sclerosis act as a trigger for the immune system to attack the brain and spinal cord.

Slowing the progression of multiple sclerosis
Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown.

7T MRI offers new insights into multiple sclerosis
Investigators from Brigham and Women's Hospital have completed a new study using 7 Tesla (7T) MRI -- a far more powerful imaging technology -- to further examine LME in MS patients

How to improve multiple sclerosis therapy
Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase.

Vaccinations not a risk factor for multiple sclerosis
Data from over 12,000 multiple sclerosis (MS) patients formed the basis of a study by the Technical University of Munich (TUM) which investigated the population's vaccination behavior in relation to MS.

Read More: Multiple Sclerosis News and Multiple Sclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.